系统性硬化症中的心脏参与:对知识差距和机会的批判性审查
Xaviar M Jones1, Nunzio Bottini2, Francesco Boin2
1Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Journal of scleroderma and related disorders
|January 23, 2025
概括
系统性硬化症 (SSc) 在高达30%的患者中可能导致心脏并发症. 本综述涵盖SSc心脏病机制,诊断和治疗方法,以改善患者的治疗结果.
科学领域:
- 心脏病学 心脏病学
- 类风湿病学 类风湿病学
- 分子生物学分子生物学
背景情况:
- 系统性硬化症 (SSc) 经常导致心血管并发症,影响到三分之一的患者.
- 早期诊断和SSc相关心脏病的管理受到复杂的病理生理学和各种表现的阻碍.
研究的目的:
- 审查SSc相关心脏病背后的分子机制.
- 讨论用于早期识别的新型诊断工具.
- 探索SSc心脏参与的新兴治疗策略.
主要方法:
- 关于SSc心脏病发生的分子机制的文献综述.
- 分析当前和新兴的诊断方式.
- 对新型和实验性治疗方法的调查.
主要成果:
- 详细检查导致SSc心脏功能障碍的分子通路.
- 突出诊断成像和生物标志物的进展.
- 确定有前途的治疗点和治疗方法.
结论:
- 了解分子机制对于管理SSc心脏病至关重要.
- 新型诊断提供了改进的早期检测能力.
- 新兴疗法有望在SSc相关的心脏病中改善患者的治疗结果.
更多相关视频
相关概念视频
Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...


